These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6984968)
41. Severe post-vaccination reaction to 17D yellow fever vaccine in Nigeria. Oyelami SA; Olaleye OD; Oyejide CO; Omilabu SA; Fatunla BA Rev Roum Virol; 1994; 45(1-2):25-30. PubMed ID: 7756161 [TBL] [Abstract][Full Text] [Related]
42. Urgent call for action: avoiding spread and re-urbanisation of yellow fever in Brazil. Possas C; Martins RM; Oliveira RL; Homma A Mem Inst Oswaldo Cruz; 2018 Jan; 113(1):1-2. PubMed ID: 29185597 [No Abstract] [Full Text] [Related]
43. [Yellow fever: the epidemiological and control aspects]. Silveira AC Rev Soc Bras Med Trop; 1998; 31 Suppl 2():75-8. PubMed ID: 10444971 [No Abstract] [Full Text] [Related]
44. [Control of Hansen's disease in an integrated health care system]. Ferreira J; Bernardi C; Gerbase A Bol Oficina Sanit Panam; 1983 Dec; 95(6):507-15. PubMed ID: 6229256 [No Abstract] [Full Text] [Related]
45. Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast. Fitzner J; Coulibaly D; Kouadio DE; Yavo JC; Loukou YG; Koudou PO; Coulombier D Vaccine; 2004 Nov; 23(2):156-62. PubMed ID: 15531032 [TBL] [Abstract][Full Text] [Related]
46. [Yellow fever antibodies in children in the Central African Republic]. Chippaux-Hyppolite C; Chippaux A Bull World Health Organ; 1966; 34(1):105-11. PubMed ID: 5295556 [No Abstract] [Full Text] [Related]
47. Epidemiological aspects of the 1969 yellow fever epidemic in Nigeria. Carey DE; Kemp GE; Troup JM; White HA; Smith EA; Addy RF; Fom AL; Pifer J; Jones EM; Brès P; Shope RE Bull World Health Organ; 1972; 46(5):645-51. PubMed ID: 4538037 [TBL] [Abstract][Full Text] [Related]
48. Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2002 Apr; 51(15):324-5. PubMed ID: 11990236 [TBL] [Abstract][Full Text] [Related]
49. Viscerotropic disease following yellow fever vaccination in Peru. Whittembury A; Ramirez G; Hernández H; Ropero AM; Waterman S; Ticona M; Brinton M; Uchuya J; Gershman M; Toledo W; Staples E; Campos C; Martínez M; Chang GJ; Cabezas C; Lanciotti R; Zaki S; Montgomery JM; Monath T; Hayes E Vaccine; 2009 Oct; 27(43):5974-81. PubMed ID: 19679215 [TBL] [Abstract][Full Text] [Related]
50. [Yellow fever: general study of the epidemic in Senegal in 1965]. Wone I; Cornet M; Ly C; Larivière M; Michel R; Guisse S; Bres P Bull Soc Med Afr Noire Lang Fr; 1966; 11(3):500-11. PubMed ID: 5973738 [No Abstract] [Full Text] [Related]
54. Jungle yellow fever, Rio de Janeiro. Filippis AM; Schatzmayr HG; Nicolai C; Baran M; Miagostovich MP; Sequeira PC; Nogueira RM Emerg Infect Dis; 2001; 7(3):484-5. PubMed ID: 11384541 [No Abstract] [Full Text] [Related]
55. [Recent data from serological surveys on the prevalence of arbovirus infections in Africa, with special reference to yellow fever]. Brès P Bull World Health Organ; 1970; 43(2):223-67. PubMed ID: 5312522 [No Abstract] [Full Text] [Related]
56. [Current aspects of the epidemiological surveillance of yellow fever]. Iversson LB AMB Rev Assoc Med Bras; 1985; 31(7-8):137-8. PubMed ID: 3879546 [No Abstract] [Full Text] [Related]